Heron Therapeutics | 보통주 자본





보통주 자본 변화 날짜
ALKERMES USD 165.1M 49K 2025-09
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
Amarin USD 20.8M 28K 2025-09
ANI Pharmaceuticals USD 21.73M 21.73M 2025-06
Anika Therapeutics USD 143K 1000 2025-03
Arrowhead Research USD 135.7M 2.44M 2025-09
Eisai JPY 282.11M 1000 2025-12
Esperion Therapeutics USD 112K 11K 2023-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Heron Therapeutics USD 1.52M 14K 2024-09
Insmed USD 212.58M 210.76M 2025-09
Ligand Pharmaceuticals USD 20K 0 2025-03
Merck USD 2.49B 15.79M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
Omeros USD 611K 17K 2023-12
Pacira USD 44.9M 44.85M 2025-06
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Surmodics USD 716K 4K 2024-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Veracyte USD 78.67M 73K 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


Heron Therapeutics 보통주 자본 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.